Retour

Harvard Bioscience Announces First Quarter 2024 Financial Results

Stocks Earnings Releases and Operating Results

Strong gross margin performance and focus on efficiency to support ongoing investments in growth Strong gross margin performance and focus on efficiency to support ongoing investments in growth

GlobeNewswire Inc. • 07/05/2024 à 13:00:00
Harvard Bioscience Inc
Address: 84 OCTOBER HILL RD
Postal Code: 01746
City: HOLLISTON
State: MA
Phone Number: (508) 893-8999
Website: https://www.harvardbioscience.com
Status: Active
Company Info

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

List Date2000-12-07
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001123494
Composite figiBBG000C58Q08
Share Class figiBBG001SG1ML8
Market Cap146,357,840 USD
SIC Code3826
SIC DescriptionLABORATORY ANALYTICAL INSTRUMENTS
Total Employees416
Share Class Shares Outstanding43430000
Weighted Shares Outstanding43429626
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
3.375
3.44
3.45
3.534
3.39
Variance
-1.89%
-0.29%
0.55%
3.73%
-3.83%
Open
3.44
3.45
3.431
3.407
3.525
Highest
3.529
3.505
3.505
3.55
3.56
Lowest
3.455
3.505
3.497
3.546
3.56
History
PeriodVarhighestlowest
1 week
-4.26%
3.56
3.455
1 month
-8.78%
3.845
3.455
3 month
-25.05%
4.648
3.455
6 month
-21.51%
4.33
3.455
1 year
-39.41%
5.98
3.455
3 year
-52.73%
7.27
1.98
5 year
44.23%
2.495
1.39
10 year
-16.46%
4.11
1.39
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-26 2023-08-08 2023-11-07 UNPUB
Assets 145,578,000 142,899,000 139,735,000 UNPUB
Current Assets 52,449,000 52,617,000 50,486,000 UNPUB
Current Liabilities 23,217,000 22,942,000 24,205,000 UNPUB
Equity 74,340,000 75,388,000 74,286,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 74,340,000 75,388,000 74,286,000 UNPUB
Liabilities 71,238,000 67,511,000 65,449,000 UNPUB
Liabilities And Equity 145,578,000 142,899,000 139,735,000 UNPUB
Noncurrent Assets 93,129,000 90,282,000 89,249,000 UNPUB
Noncurrent Liabilities 48,021,000 44,569,000 41,244,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-26 2023-08-08 2023-11-07 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -793,000 552,000 1,210,000 UNPUB
Net Cash Flow, Continuing -793,000 552,000 1,210,000 UNPUB
Net Cash Flow From Financing Activities -2,893,000 -2,375,000 -2,750,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -2,893,000 -2,375,000 -2,750,000 UNPUB
Net Cash Flow From Investing Activities 288,000 -625,000 -401,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 288,000 -625,000 -401,000 UNPUB
Net Cash Flow From Operating Activities 1,812,000 3,552,000 4,361,000 UNPUB
Net Cash Flow From Operating Activities, Continuing 1,812,000 3,552,000 4,361,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-26 2023-08-08 2023-11-07 UNPUB
Comprehensive Income/Loss 1,019,000 -379,000 -2,465,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent 1,019,000 -379,000 -2,465,000 UNPUB
Other Comprehensive Income/Loss 397,000 601,000 -1,226,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-04-26 2023-08-08 2023-11-07 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 28,768,000 30,857,000 25,925,000 UNPUB
Cost Of Revenue 11,629,000 12,086,000 10,636,000 UNPUB
Costs And Expenses 28,768,000 30,857,000 25,925,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 18,346,000 16,673,000 14,727,000 UNPUB
Income/Loss From Continuing Operations After Tax 622,000 -980,000 -1,239,000 UNPUB
Income/Loss From Continuing Operations Before Tax 1,207,000 -2,098,000 -562,000 UNPUB
Income Tax Expense/Benefit 585,000 -1,118,000 677,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 622,000 -980,000 -1,239,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent 622,000 -980,000 -1,239,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic 622,000 -980,000 -1,239,000 UNPUB
Operating Expenses 16,597,000 15,877,000 15,660,000 UNPUB
Operating Income/Loss 1,749,000 796,000 -933,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 29,975,000 28,759,000 25,363,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-04 2022-11-09 2023-03-09
Assets 158,044,000 155,273,000 147,013,000 145,360,000
Current Assets 59,448,000 56,498,000 51,818,000 51,124,000
Current Liabilities 27,226,000 23,354,000 21,360,000 23,249,000
Equity 76,375,000 77,504,000 71,979,000 72,220,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 76,375,000 77,504,000 71,979,000 72,220,000
Liabilities 81,669,000 77,769,000 75,034,000 73,140,000
Liabilities And Equity 158,044,000 155,273,000 147,013,000 145,360,000
Noncurrent Assets 98,596,000 98,775,000 95,195,000 94,236,000
Noncurrent Liabilities 0 0 53,674,000 49,891,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-04 2022-11-09 2023-03-09
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -2,363,000 -1,210,000 584,000 -3,275,000
Net Cash Flow, Continuing -2,363,000 -1,210,000 584,000 -3,275,000
Net Cash Flow From Financing Activities 94,000 -578,000 377,000 -2,837,000
Net Cash Flow From Financing Activities, Continuing 94,000 -578,000 377,000 -2,837,000
Net Cash Flow From Investing Activities -471,000 -442,000 -442,000 -1,590,000
Net Cash Flow From Investing Activities, Continuing -471,000 -442,000 -442,000 -1,590,000
Net Cash Flow From Operating Activities -1,986,000 -190,000 649,000 1,152,000
Net Cash Flow From Operating Activities, Continuing -1,986,000 -190,000 649,000 1,152,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-04 2022-11-09 2023-03-09
Comprehensive Income/Loss -7,579,000 -82,000 -6,341,000 -14,541,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,579,000 -82,000 -6,341,000 -14,541,000
Other Comprehensive Income/Loss -699,000 -2,517,000 -2,936,000 -5,025,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-04 2022-11-09 2023-03-09
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 35,796,000 25,787,000 31,612,000 122,514,000
Cost Of Revenue 12,601,000 12,571,000 14,750,000 52,516,000
Costs And Expenses 35,796,000 25,787,000 31,612,000 122,514,000
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit 16,177,000 16,637,000 12,172,000 60,819,000
Income/Loss From Continuing Operations After Tax -6,880,000 2,435,000 -3,405,000 -9,516,000
Income/Loss From Continuing Operations Before Tax -7,018,000 3,421,000 -4,690,000 -9,179,000
Income Tax Expense/Benefit -138,000 986,000 -1,285,000 337,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -6,880,000 2,435,000 -3,405,000 -9,516,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -6,880,000 2,435,000 -3,405,000 -9,516,000
Net Income/Loss Available To Common Stockholders, Basic -6,880,000 2,435,000 -3,405,000 -9,516,000
Operating Expenses 22,889,000 12,639,000 15,934,000 67,752,000
Operating Income/Loss -6,712,000 3,998,000 -3,762,000 -6,933,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 28,778,000 29,208,000 26,922,000 113,335,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-07 2021-08-06 2021-11-05 2022-03-11
Assets 151,249,000 153,971,000 153,872,000 162,344,000
Current Assets 49,223,000 53,557,000 55,686,000 61,583,000
Current Liabilities 20,718,000 23,268,000 23,506,000 25,316,000
Equity 77,115,000 78,701,000 76,887,000 83,401,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 77,115,000 78,701,000 76,887,000 83,401,000
Liabilities 74,134,000 75,270,000 76,985,000 78,943,000
Liabilities And Equity 151,249,000 153,971,000 153,872,000 162,344,000
Noncurrent Assets 102,026,000 100,414,000 98,186,000 100,761,000
Noncurrent Liabilities 0 0 53,479,000 53,627,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-07 2021-08-06 2021-11-05 2022-03-11
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -2,405,000 370,000 -653,000 -335,000
Net Cash Flow, Continuing -2,405,000 370,000 -653,000 -335,000
Net Cash Flow From Financing Activities -3,141,000 -192,000 487,000 -252,000
Net Cash Flow From Financing Activities, Continuing -3,141,000 -192,000 487,000 -252,000
Net Cash Flow From Investing Activities -301,000 -206,000 -480,000 -1,345,000
Net Cash Flow From Investing Activities, Continuing -301,000 -206,000 -480,000 -1,345,000
Net Cash Flow From Operating Activities 1,037,000 768,000 -660,000 1,262,000
Net Cash Flow From Operating Activities, Continuing 1,037,000 768,000 -660,000 1,262,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-07 2021-08-06 2021-11-05 2022-03-11
Comprehensive Income/Loss -1,994,000 113,000 -1,305,000 2,751,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,994,000 113,000 -1,305,000 2,751,000
Other Comprehensive Income/Loss -1,325,000 523,000 -1,135,000 3,039,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-07 2021-08-06 2021-11-05 2022-03-11
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 27,673,000 29,829,000 29,618,000 119,044,000
Cost Of Revenue 11,558,000 12,844,000 13,355,000 51,252,000
Costs And Expenses 27,673,000 29,829,000 29,618,000 119,044,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 15,431,000 16,353,000 16,308,000 67,652,000
Income/Loss From Continuing Operations After Tax -669,000 -410,000 -170,000 -288,000
Income/Loss From Continuing Operations Before Tax -684,000 -632,000 45,000 -140,000
Income Tax Expense/Benefit -15,000 -222,000 215,000 148,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -669,000 -410,000 -170,000 -288,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -669,000 -410,000 -170,000 -288,000
Net Income/Loss Available To Common Stockholders, Basic -669,000 -410,000 -170,000 -288,000
Operating Expenses 15,670,000 16,295,000 15,760,000 65,586,000
Operating Income/Loss -239,000 58,000 548,000 2,066,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 26,989,000 29,197,000 29,663,000 118,904,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-06 2021-03-12
Assets 156,260,000 150,685,000 149,614,000 156,254,000
Current Assets 48,165,000 44,102,000 43,520,000 51,700,000
Current Liabilities 23,475,000 22,663,000 21,248,000 21,053,000
Equity 76,009,000 76,068,000 77,167,000 76,681,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 76,009,000 76,068,000 77,167,000 76,681,000
Liabilities 80,251,000 74,617,000 72,447,000 79,573,000
Liabilities And Equity 156,260,000 150,685,000 149,614,000 156,254,000
Noncurrent Assets 108,095,000 106,583,000 106,094,000 104,554,000
Noncurrent Liabilities 0 0 51,199,000 58,520,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-06 2021-03-12
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -2,441,000 -3,210,000 80,000 -38,000
Net Cash Flow, Continuing -2,441,000 -3,210,000 80,000 -38,000
Net Cash Flow From Financing Activities -5,071,000 -5,300,000 -953,000 -7,967,000
Net Cash Flow From Financing Activities, Continuing -5,071,000 -5,300,000 -953,000 -7,967,000
Net Cash Flow From Investing Activities -241,000 -283,000 -564,000 -1,402,000
Net Cash Flow From Investing Activities, Continuing -241,000 -283,000 -564,000 -1,402,000
Net Cash Flow From Operating Activities 2,871,000 2,373,000 1,597,000 9,331,000
Net Cash Flow From Operating Activities, Continuing 2,871,000 2,373,000 1,597,000 9,331,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-06 2021-03-12
Comprehensive Income/Loss -6,236,000 -876,000 632,000 -8,187,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -6,236,000 -876,000 632,000 -8,187,000
Other Comprehensive Income/Loss -1,720,000 705,000 1,730,000 -377,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-08 2020-08-10 2020-11-06 2021-03-12
Basic Earnings Per Share 0 0 UNPUB UNPUB
Benefits Costs and Expenses 28,232,000 24,176,000 25,452,000 109,392,000
Cost Of Revenue 10,789,000 9,452,000 10,542,000 44,059,000
Costs And Expenses 28,232,000 24,176,000 25,452,000 109,392,000
Diluted Earnings Per Share 0 0 UNPUB UNPUB
Gross Profit 12,982,000 13,856,000 13,495,000 58,041,000
Income/Loss From Continuing Operations After Tax -4,516,000 -1,581,000 -1,098,000 -7,810,000
Income/Loss From Continuing Operations Before Tax -4,461,000 -868,000 -1,415,000 -7,292,000
Income Tax Expense/Benefit 55,000 713,000 -317,000 518,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,516,000 -1,581,000 -1,098,000 -7,810,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,516,000 -1,581,000 -1,098,000 -7,810,000
Net Income/Loss Available To Common Stockholders, Basic -4,516,000 -1,581,000 -1,098,000 -7,810,000
Operating Expenses 16,255,000 13,300,000 13,313,000 57,820,000
Operating Income/Loss -3,273,000 556,000 182,000 221,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 23,771,000 23,308,000 24,037,000 102,100,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-08 2019-11-08 2020-03-16
Assets 171,336,000 166,238,000 162,777,000 164,870,000
Current Assets 53,597,000 52,493,000 52,289,000 53,572,000
Current Liabilities 24,141,000 20,861,000 21,697,000 25,312,000
Equity 80,349,000 80,330,000 77,103,000 81,694,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 80,349,000 80,330,000 77,103,000 81,694,000
Liabilities 90,987,000 85,908,000 85,674,000 83,176,000
Liabilities And Equity 171,336,000 166,238,000 162,777,000 164,870,000
Noncurrent Assets 117,739,000 113,745,000 110,488,000 111,298,000
Noncurrent Liabilities 0 0 63,977,000 57,864,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-08 2019-11-08 2020-03-16
Exchange Gains/Losses 3,000 40,000 -228,000 UNPUB
Net Cash Flow -3,143,000 -96,000 1,911,000 192,000
Net Cash Flow, Continuing -3,146,000 -136,000 2,139,000 192,000
Net Cash Flow From Financing Activities -5,004,000 -1,533,000 -658,000 -7,624,000
Net Cash Flow From Financing Activities, Continuing -5,004,000 -1,533,000 -658,000 -7,624,000
Net Cash Flow From Investing Activities -152,000 740,000 -361,000 -229,000
Net Cash Flow From Investing Activities, Continuing -152,000 740,000 -361,000 -229,000
Net Cash Flow From Operating Activities 2,010,000 657,000 3,158,000 8,045,000
Net Cash Flow From Operating Activities, Continuing 2,010,000 657,000 3,158,000 8,045,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-08 2019-11-08 2020-03-16
Comprehensive Income/Loss -2,370,000 -247,000 -2,620,000 -3,844,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,545,000 -721,000 -4,156,000 -3,844,000
Other Comprehensive Income/Loss -175,000 -474,000 -1,536,000 843,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-08 2019-08-08 2019-11-08 2020-03-16
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 29,996,000 30,716,000 30,092,000 121,678,000
Cost Of Revenue 12,048,000 13,629,000 12,439,000 51,854,000
Costs And Expenses 29,996,000 30,716,000 30,092,000 121,678,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 16,154,000 15,955,000 14,979,000 64,322,000
Income/Loss From Continuing Operations After Tax -2,370,000 -247,000 -2,620,000 -4,687,000
Income/Loss From Continuing Operations Before Tax -1,794,000 -1,132,000 -2,674,000 -5,502,000
Income Tax Expense/Benefit 576,000 -885,000 -54,000 -815,000
Interest Expense, Operating 1,405,000 1,376,000 1,348,000 UNPUB
Net Income/Loss -2,370,000 -247,000 -2,620,000 -4,687,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,370,000 -247,000 -2,620,000 -4,687,000
Net Income/Loss Available To Common Stockholders, Basic -2,370,000 -247,000 -2,620,000 -4,687,000
Operating Expenses 16,273,000 15,727,000 16,344,000 63,945,000
Operating Income/Loss -119,000 228,000 -1,365,000 377,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 28,202,000 29,584,000 27,418,000 116,176,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-02 2018-11-01 2019-03-18
Assets 170,947,000 165,050,000 165,040,000 168,613,000
Current Assets 55,810,000 53,692,000 54,528,000 57,832,000
Current Liabilities 22,284,000 22,194,000 19,261,000 21,506,000
Equity 79,294,000 77,012,000 80,959,000 82,724,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 79,294,000 77,012,000 80,959,000 82,724,000
Liabilities 91,653,000 88,038,000 84,081,000 85,889,000
Liabilities And Equity 170,947,000 165,050,000 165,040,000 168,613,000
Noncurrent Assets 115,137,000 111,358,000 110,512,000 110,781,000
Noncurrent Liabilities 69,369,000 65,844,000 64,820,000 64,383,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-02 2018-11-01 2019-03-18
Exchange Gains/Losses 755,000 -382,000 26,000 299,000
Net Cash Flow 258,000 -367,000 1,037,000 2,440,000
Net Cash Flow, Continuing -497,000 15,000 1,011,000 2,141,000
Net Cash Flow From Financing Activities 51,244,000 -539,000 2,702,000 53,053,000
Net Cash Flow From Financing Activities, Continuing 51,244,000 -539,000 2,702,000 53,053,000
Net Cash Flow From Investing Activities -52,189,000 -723,000 -257,000 -53,796,000
Net Cash Flow From Investing Activities, Continuing -52,189,000 -723,000 -257,000 -53,796,000
Net Cash Flow From Operating Activities 448,000 1,277,000 -1,434,000 2,884,000
Net Cash Flow From Operating Activities, Continuing 448,000 1,277,000 -1,434,000 2,884,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-02 2018-11-01 2019-03-18
Comprehensive Income/Loss -4,064,000 -1,464,000 -256,000 -5,778,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,837,000 -4,177,000 320,000 -5,778,000
Other Comprehensive Income/Loss 1,227,000 0 0 -2,856,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -732,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-10 2018-08-02 2018-11-01 2019-03-18
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 32,004,000 33,389,000 29,543,000 128,749,000
Cost Of Revenue 13,490,000 16,167,000 12,818,000 57,593,000
Costs And Expenses 32,004,000 33,389,000 29,543,000 128,749,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 13,269,000 15,355,000 15,817,000 63,181,000
Income/Loss From Continuing Operations After Tax -5,850,000 -1,498,000 -256,000 -4,299,000
Income/Loss From Continuing Operations Before Tax -5,245,000 -1,867,000 -908,000 -7,975,000
Income Tax Expense/Benefit 605,000 -369,000 -652,000 -3,676,000
Interest Expense, Operating 894,000 1,483,000 1,458,000 5,367,000
Net Income/Loss -4,064,000 -1,464,000 -256,000 -2,922,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,064,000 -1,464,000 -256,000 -2,922,000
Net Income/Loss Available To Common Stockholders, Basic -4,064,000 -1,464,000 -256,000 -2,922,000
Operating Expenses 14,535,000 15,737,000 14,927,000 62,197,000
Operating Income/Loss -1,266,000 -382,000 890,000 984,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 26,759,000 31,522,000 28,635,000 120,774,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-08 2017-08-03 2017-11-02 2018-03-16
Assets 107,396,000 108,859,000 110,678,000 109,354,000
Current Assets 45,121,000 45,838,000 47,399,000 47,535,000
Current Liabilities 14,056,000 13,239,000 13,947,000 14,041,000
Equity 72,715,000 75,212,000 76,905,000 80,900,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 72,715,000 75,212,000 76,905,000 80,900,000
Liabilities 34,681,000 33,647,000 33,773,000 28,454,000
Liabilities And Equity 107,396,000 108,859,000 110,678,000 109,354,000
Noncurrent Assets 62,275,000 63,021,000 63,279,000 61,819,000
Noncurrent Liabilities 20,625,000 20,408,000 19,826,000 14,413,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-08 2017-08-03 2017-11-02 2018-03-16
Exchange Gains/Losses 109,000 259,000 -55,000 1,789,000
Net Cash Flow -997,000 125,000 1,112,000 137,000
Net Cash Flow, Continuing -1,106,000 -134,000 1,167,000 -1,652,000
Net Cash Flow From Financing Activities -268,000 -361,000 -724,000 -1,792,000
Net Cash Flow From Financing Activities, Continuing -268,000 -361,000 -724,000 -1,792,000
Net Cash Flow From Investing Activities 228,000 -704,000 -240,000 -917,000
Net Cash Flow From Investing Activities, Continuing 228,000 -704,000 -240,000 -917,000
Net Cash Flow From Operating Activities -610,000 475,000 2,131,000 1,057,000
Net Cash Flow From Operating Activities, Continuing -610,000 475,000 2,131,000 1,057,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-08 2017-08-03 2017-11-02 2018-03-16
Comprehensive Income/Loss -1,066,000 -381,000 -417,000 5,117,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -117,000 1,611,000 785,000 5,117,000
Other Comprehensive Income/Loss 949,000 0 0 5,982,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -958,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-08 2017-08-03 2017-11-02 2018-03-16
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 25,199,000 25,675,000 25,460,000 103,970,000
Cost Of Revenue 12,657,000 13,926,000 13,411,000 54,285,000
Costs And Expenses 25,199,000 25,675,000 25,460,000 103,970,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 11,499,000 11,287,000 11,639,000 47,597,000
Income/Loss From Continuing Operations After Tax -1,066,000 -381,000 -417,000 -865,000
Income/Loss From Continuing Operations Before Tax -1,043,000 -462,000 -410,000 -2,088,000
Income Tax Expense/Benefit 23,000 -81,000 7,000 -1,223,000
Interest Expense, Operating 162,000 183,000 189,000 713,000
Net Income/Loss -1,066,000 -381,000 -417,000 -865,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,066,000 -381,000 -417,000 -865,000
Net Income/Loss Available To Common Stockholders, Basic -1,066,000 -381,000 -417,000 -865,000
Operating Expenses 12,138,000 11,286,000 11,775,000 47,698,000
Operating Income/Loss -639,000 1,000 -136,000 -101,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 24,156,000 25,213,000 25,050,000 101,882,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-04 2016-11-03 2017-03-17
Assets 117,880,000 114,085,000 112,176,000 107,765,000
Current Assets 48,742,000 46,819,000 46,154,000 45,472,000
Current Liabilities 15,896,000 14,850,000 14,442,000 14,601,000
Equity 78,195,000 76,663,000 75,891,000 72,196,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 78,195,000 76,663,000 75,891,000 72,196,000
Liabilities 39,685,000 37,422,000 36,285,000 35,569,000
Liabilities And Equity 117,880,000 114,085,000 112,176,000 107,765,000
Noncurrent Assets 69,138,000 67,266,000 66,022,000 62,293,000
Noncurrent Liabilities 23,789,000 22,572,000 21,843,000 20,968,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-04 2016-11-03 2017-03-17
Exchange Gains/Losses 88,000 -371,000 -160,000 -1,601,000
Net Cash Flow -2,569,000 -544,000 1,714,000 -1,148,000
Net Cash Flow, Continuing -2,657,000 -173,000 1,874,000 453,000
Net Cash Flow From Financing Activities -1,726,000 -908,000 -1,024,000 -4,868,000
Net Cash Flow From Financing Activities, Continuing -1,726,000 -908,000 -1,024,000 -4,868,000
Net Cash Flow From Investing Activities -205,000 -207,000 -542,000 -62,000
Net Cash Flow From Investing Activities, Continuing -205,000 -207,000 -542,000 -62,000
Net Cash Flow From Operating Activities -726,000 942,000 3,440,000 5,383,000
Net Cash Flow From Operating Activities, Continuing -726,000 942,000 3,440,000 5,383,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-04 2016-11-03 2017-03-17
Comprehensive Income/Loss -636,000 -713,000 -1,638,000 -9,081,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -43,000 -2,536,000 -3,625,000 -9,081,000
Other Comprehensive Income/Loss 0 0 0 -4,774,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -2,458,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-16 2016-08-04 2016-11-03 2017-03-17
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 27,406,000 26,903,000 25,887,000 107,599,000
Cost Of Revenue 14,018,000 14,461,000 13,317,000 56,106,000
Costs And Expenses 27,406,000 26,903,000 25,887,000 107,599,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 12,945,000 11,675,000 11,690,000 48,415,000
Income/Loss From Continuing Operations After Tax -636,000 -713,000 -1,638,000 -4,307,000
Income/Loss From Continuing Operations Before Tax -443,000 -767,000 -880,000 -3,078,000
Income Tax Expense/Benefit 193,000 -54,000 758,000 1,229,000
Interest Expense, Operating 164,000 180,000 142,000 642,000
Net Income/Loss -636,000 -713,000 -1,638,000 -4,307,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -636,000 -713,000 -1,638,000 -4,307,000
Net Income/Loss Available To Common Stockholders, Basic -636,000 -713,000 -1,638,000 -4,307,000
Operating Expenses 13,166,000 12,515,000 12,503,000 51,412,000
Operating Income/Loss -221,000 -840,000 -813,000 -2,997,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 26,963,000 26,136,000 25,007,000 104,521,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-06 2015-11-05 2016-04-29
Assets 134,122,000 138,577,000 133,555,000 120,217,000
Current Assets 52,771,000 56,542,000 52,324,000 50,549,000
Current Liabilities 19,762,000 21,233,000 17,270,000 19,409,000
Equity 90,503,000 94,813,000 94,286,000 77,598,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 90,503,000 94,813,000 94,286,000 77,598,000
Liabilities 43,619,000 43,764,000 39,269,000 42,619,000
Liabilities And Equity 134,122,000 138,577,000 133,555,000 120,217,000
Noncurrent Assets 81,351,000 82,035,000 81,231,000 69,668,000
Noncurrent Liabilities 23,857,000 22,531,000 21,999,000 23,210,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-06 2015-11-05 2016-04-29
Exchange Gains/Losses -849,000 236,000 -156,000 -38,000
Net Cash Flow -6,103,000 -629,000 -1,312,000 -7,390,000
Net Cash Flow, Continuing -5,254,000 -865,000 -1,156,000 -7,352,000
Net Cash Flow From Financing Activities 832,000 200,000 -411,000 -540,000
Net Cash Flow From Financing Activities, Continuing 832,000 200,000 -411,000 -540,000
Net Cash Flow From Investing Activities -5,589,000 -581,000 -667,000 -7,517,000
Net Cash Flow From Investing Activities, Continuing -5,589,000 -581,000 -667,000 -7,517,000
Net Cash Flow From Operating Activities -497,000 -484,000 -78,000 705,000
Net Cash Flow From Operating Activities, Continuing -497,000 -484,000 -78,000 705,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-06 2015-11-05 2016-04-29
Comprehensive Income/Loss -1,401,000 349,000 -847,000 -22,690,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -5,931,000 2,121,000 -1,390,000 -22,690,000
Other Comprehensive Income/Loss -4,530,000 0 0 -3,651,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -2,280,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-07 2015-08-06 2015-11-05 2016-04-29
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses 27,527,000 29,227,000 26,827,000 112,272,000
Cost Of Revenue 14,285,000 16,205,000 14,005,000 59,941,000
Costs And Expenses 27,527,000 29,227,000 26,827,000 112,272,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 11,478,000 12,595,000 11,726,000 48,723,000
Income/Loss From Continuing Operations After Tax -1,401,000 349,000 -847,000 -19,039,000
Income/Loss From Continuing Operations Before Tax -1,764,000 -427,000 -1,096,000 -3,608,000
Income Tax Expense/Benefit -363,000 -776,000 -249,000 15,431,000
Interest Expense, Operating 222,000 215,000 204,000 854,000
Net Income/Loss -1,401,000 349,000 -847,000 -19,039,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,401,000 349,000 -847,000 -19,039,000
Net Income/Loss Available To Common Stockholders, Basic -1,401,000 349,000 -847,000 -19,039,000
Operating Expenses 12,628,000 12,496,000 12,501,000 50,436,000
Operating Income/Loss -1,150,000 99,000 -775,000 -1,713,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 25,763,000 28,800,000 25,731,000 108,664,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-06 2015-03-12
Assets UNPUB UNPUB 136,128,000 135,916,000
Current Assets UNPUB UNPUB 65,001,000 57,063,000
Current Liabilities UNPUB UNPUB 15,628,000 18,099,000
Equity UNPUB UNPUB 96,776,000 95,468,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 96,776,000 95,468,000
Liabilities UNPUB UNPUB 39,352,000 40,448,000
Liabilities And Equity UNPUB UNPUB 136,128,000 135,916,000
Noncurrent Assets UNPUB UNPUB 71,127,000 78,853,000
Noncurrent Liabilities UNPUB UNPUB 23,724,000 22,349,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-06 2015-03-12
Exchange Gains/Losses UNPUB UNPUB -1,184,000 -1,237,000
Net Cash Flow UNPUB UNPUB 300,000 -11,637,000
Net Cash Flow, Continuing UNPUB UNPUB 1,484,000 -10,400,000
Net Cash Flow From Financing Activities UNPUB UNPUB 1,364,000 -1,234,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 1,364,000 -1,234,000
Net Cash Flow From Investing Activities UNPUB UNPUB -482,000 -13,517,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -482,000 -13,517,000
Net Cash Flow From Operating Activities UNPUB UNPUB 602,000 4,351,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB 602,000 4,351,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-06 2015-03-12
Comprehensive Income/Loss UNPUB UNPUB 633,000 -3,234,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -2,481,000 -3,234,000
Other Comprehensive Income/Loss UNPUB UNPUB 0 -5,589,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -3,557,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-06 2015-03-12
Basic Earnings Per Share UNPUB UNPUB 0 0
Benefits Costs and Expenses UNPUB UNPUB 24,492,000 104,246,000
Cost Of Revenue UNPUB UNPUB 14,006,000 59,319,000
Costs And Expenses UNPUB UNPUB 24,492,000 104,246,000
Diluted Earnings Per Share UNPUB UNPUB 0 0
Gross Profit UNPUB UNPUB 11,442,000 49,344,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB 633,000 2,355,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB 956,000 4,417,000
Income Tax Expense/Benefit UNPUB UNPUB 323,000 2,062,000
Interest Expense, Operating UNPUB UNPUB 239,000 990,000
Net Income/Loss UNPUB UNPUB 633,000 2,355,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB 633,000 2,355,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB 633,000 2,355,000
Operating Expenses UNPUB UNPUB 10,017,000 42,726,000
Operating Income/Loss UNPUB UNPUB 1,425,000 6,618,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 0 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 0 0
Revenues UNPUB UNPUB 25,448,000 108,663,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-10 2013-08-09 2013-11-08 2014-03-14
Assets 135,437,000 146,048,000 148,337,000 135,460,000
Current Assets 61,883,000 72,776,000 73,935,000 60,750,000
Current Liabilities 13,116,000 13,296,000 13,495,000 16,085,000
Equity 104,382,000 105,375,000 107,835,000 94,485,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 104,382,000 105,375,000 107,835,000 94,485,000
Liabilities 31,055,000 40,673,000 40,502,000 40,975,000
Liabilities And Equity 135,437,000 146,048,000 148,337,000 135,460,000
Noncurrent Assets 73,554,000 73,272,000 74,402,000 74,710,000
Noncurrent Liabilities 17,939,000 27,377,000 27,007,000 24,890,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-10 2013-08-09 2013-11-08 2014-03-14
Exchange Gains/Losses -756,000 134,000 885,000 791,000
Net Cash Flow 3,068,000 10,349,000 2,833,000 5,090,000
Net Cash Flow, Continuing 3,824,000 10,215,000 1,948,000 4,299,000
Net Cash Flow From Financing Activities 3,602,000 9,696,000 -751,000 68,000
Net Cash Flow From Financing Activities, Continuing 3,602,000 9,696,000 -751,000 68,000
Net Cash Flow From Investing Activities -354,000 -285,000 1,268,000 171,000
Net Cash Flow From Investing Activities, Continuing -354,000 -285,000 1,268,000 171,000
Net Cash Flow From Operating Activities 576,000 804,000 1,431,000 4,060,000
Net Cash Flow From Operating Activities, Continuing 576,000 804,000 1,431,000 4,060,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-10 2013-08-09 2013-11-08 2014-03-14
Comprehensive Income/Loss 96,000 -186,000 -984,000 389,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,941,000 -39,000 1,404,000 389,000
Other Comprehensive Income/Loss 0 0 0 2,219,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -3,878,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-10 2013-08-09 2013-11-08 2014-03-14
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 24,855,000 25,678,000 25,081,000 104,736,000
Cost Of Revenue 13,826,000 14,005,000 13,838,000 57,475,000
Costs And Expenses 24,855,000 25,678,000 25,081,000 104,736,000
Diluted Earnings Per Share 0 0 0 0
Gross Profit 12,260,000 12,089,000 11,299,000 47,696,000
Income/Loss From Continuing Operations After Tax 932,000 95,000 -49,000 723,000
Income/Loss From Continuing Operations Before Tax 1,231,000 416,000 56,000 435,000
Income Tax Expense/Benefit 299,000 321,000 105,000 -288,000
Interest Expense, Operating 130,000 245,000 276,000 955,000
Net Income/Loss 96,000 -186,000 -984,000 -1,830,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 96,000 -186,000 -984,000 -1,830,000
Net Income/Loss Available To Common Stockholders, Basic 96,000 -186,000 -984,000 -1,830,000
Operating Expenses 10,934,000 11,343,000 10,885,000 46,159,000
Operating Income/Loss 1,326,000 746,000 414,000 1,537,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 26,086,000 26,094,000 25,137,000 105,171,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-18
Assets UNPUB UNPUB UNPUB 133,484,000
Current Assets UNPUB UNPUB UNPUB 58,972,000
Current Liabilities UNPUB UNPUB UNPUB 9,901,000
Equity UNPUB UNPUB UNPUB 104,213,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 104,213,000
Liabilities UNPUB UNPUB UNPUB 29,271,000
Liabilities And Equity UNPUB UNPUB UNPUB 133,484,000
Noncurrent Assets UNPUB UNPUB UNPUB 74,512,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 19,370,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-18
Exchange Gains/Losses UNPUB UNPUB UNPUB 442,000
Net Cash Flow UNPUB UNPUB UNPUB 2,765,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 2,323,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB -1,063,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB -1,063,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -4,676,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -4,676,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB 8,062,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB 8,062,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-18
Comprehensive Income/Loss UNPUB UNPUB UNPUB 3,229,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 3,229,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 3,229,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -4,573,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-18
Basic Earnings Per Share UNPUB UNPUB UNPUB 0
Benefits Costs and Expenses UNPUB UNPUB UNPUB 108,943,000
Cost Of Revenue UNPUB UNPUB UNPUB 58,753,000
Costs And Expenses UNPUB UNPUB UNPUB 108,943,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB 0
Gross Profit UNPUB UNPUB UNPUB 52,418,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB 1,532,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB 2,228,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 696,000
Interest Expense, Operating UNPUB UNPUB UNPUB 584,000
Net Income/Loss UNPUB UNPUB UNPUB 2,370,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 2,370,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB 2,370,000
Operating Expenses UNPUB UNPUB UNPUB 49,252,000
Operating Income/Loss UNPUB UNPUB UNPUB 3,166,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 111,171,000
Calendar
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:HBIO240517P00008000 OPASPS Put American 100 8 EMLD 2024-05-17
O:HBIO240517P00007000 OPASPS Put American 100 7 EMLD 2024-05-17
O:HBIO240517P00006000 OPASPS Put American 100 6 EMLD 2024-05-17
O:HBIO240517P00005000 OPASPS Put American 100 5 EMLD 2024-05-17
O:HBIO240517P00004000 OPASPS Put American 100 4 EMLD 2024-05-17
O:HBIO240517P00003000 OPASPS Put American 100 3 EMLD 2024-05-17
O:HBIO240517P00002000 OPASPS Put American 100 2 EMLD 2024-05-17
O:HBIO240517P00001000 OPASPS Put American 100 1 EMLD 2024-05-17
O:HBIO240517C00008000 OCASPS Call American 100 8 EMLD 2024-05-17
O:HBIO240517C00007000 OCASPS Call American 100 7 EMLD 2024-05-17
O:HBIO240517C00006000 OCASPS Call American 100 6 EMLD 2024-05-17
O:HBIO240517C00005000 OCASPS Call American 100 5 EMLD 2024-05-17
O:HBIO240517C00004000 OCASPS Call American 100 4 EMLD 2024-05-17
O:HBIO240517C00003000 OCASPS Call American 100 3 EMLD 2024-05-17
O:HBIO240517C00002000 OCASPS Call American 100 2 EMLD 2024-05-17
O:HBIO240517C00001000 OCASPS Call American 100 1 EMLD 2024-05-17
O:HBIO240419P00009000 OPASPS Put American 100 9 EMLD 2024-04-19
O:HBIO240419P00008000 OPASPS Put American 100 8 EMLD 2024-04-19
O:HBIO240419P00007000 OPASPS Put American 100 7 EMLD 2024-04-19
O:HBIO240419P00006000 OPASPS Put American 100 6 EMLD 2024-04-19
O:HBIO240419P00005000 OPASPS Put American 100 5 EMLD 2024-04-19
O:HBIO240419P00004000 OPASPS Put American 100 4 EMLD 2024-04-19
O:HBIO240419P00003000 OPASPS Put American 100 3 EMLD 2024-04-19
O:HBIO240419P00002000 OPASPS Put American 100 2 EMLD 2024-04-19
O:HBIO240419P00001000 OPASPS Put American 100 1 EMLD 2024-04-19
O:HBIO240419C00009000 OCASPS Call American 100 9 EMLD 2024-04-19
O:HBIO240419C00008000 OCASPS Call American 100 8 EMLD 2024-04-19
O:HBIO240419C00007000 OCASPS Call American 100 7 EMLD 2024-04-19
O:HBIO240419C00006000 OCASPS Call American 100 6 EMLD 2024-04-19
O:HBIO240419C00005000 OCASPS Call American 100 5 EMLD 2024-04-19
O:HBIO240419C00004000 OCASPS Call American 100 4 EMLD 2024-04-19
O:HBIO240419C00003000 OCASPS Call American 100 3 EMLD 2024-04-19
O:HBIO240419C00002000 OCASPS Call American 100 2 EMLD 2024-04-19
O:HBIO240419C00001000 OCASPS Call American 100 1 EMLD 2024-04-19
O:HBIO240315P00009000 OPASPS Put American 100 9 EMLD 2024-03-15
O:HBIO240315P00008000 OPASPS Put American 100 8 EMLD 2024-03-15
O:HBIO240315P00007000 OPASPS Put American 100 7 EMLD 2024-03-15
O:HBIO240315P00006000 OPASPS Put American 100 6 EMLD 2024-03-15
O:HBIO240315P00005000 OPASPS Put American 100 5 EMLD 2024-03-15
O:HBIO240315P00004000 OPASPS Put American 100 4 EMLD 2024-03-15
O:HBIO240315P00003000 OPASPS Put American 100 3 EMLD 2024-03-15
O:HBIO240315P00002000 OPASPS Put American 100 2 EMLD 2024-03-15
O:HBIO240315P00001000 OPASPS Put American 100 1 EMLD 2024-03-15
O:HBIO240315C00009000 OCASPS Call American 100 9 EMLD 2024-03-15
O:HBIO240315C00008000 OCASPS Call American 100 8 EMLD 2024-03-15
O:HBIO240315C00007000 OCASPS Call American 100 7 EMLD 2024-03-15
O:HBIO240315C00006000 OCASPS Call American 100 6 EMLD 2024-03-15
O:HBIO240315C00005000 OCASPS Call American 100 5 EMLD 2024-03-15
O:HBIO240315C00004000 OCASPS Call American 100 4 EMLD 2024-03-15
O:HBIO240315C00003000 OCASPS Call American 100 3 EMLD 2024-03-15
O:HBIO240315C00002000 OCASPS Call American 100 2 EMLD 2024-03-15
O:HBIO240315C00001000 OCASPS Call American 100 1 EMLD 2024-03-15
O:HBIO240216P00002000 OPASPS Put American 100 2 EMLD 2024-02-16
O:HBIO240216P00001000 OPASPS Put American 100 1 EMLD 2024-02-16
O:HBIO240216C00011000 OCASPS Call American 100 11 EMLD 2024-02-16
O:HBIO240216C00010000 OCASPS Call American 100 10 EMLD 2024-02-16
O:HBIO240216C00009000 OCASPS Call American 100 9 EMLD 2024-02-16
O:HBIO240216C00008000 OCASPS Call American 100 8 EMLD 2024-02-16
O:HBIO240216C00007000 OCASPS Call American 100 7 EMLD 2024-02-16
O:HBIO240216C00006000 OCASPS Call American 100 6 EMLD 2024-02-16
O:HBIO240216C00005000 OCASPS Call American 100 5 EMLD 2024-02-16
O:HBIO240216C00004000 OCASPS Call American 100 4 EMLD 2024-02-16
O:HBIO240216C00003000 OCASPS Call American 100 3 EMLD 2024-02-16
O:HBIO240216C00002000 OCASPS Call American 100 2 EMLD 2024-02-16
O:HBIO240216C00001000 OCASPS Call American 100 1 EMLD 2024-02-16
O:HBIO240216P00011000 OPASPS Put American 100 11 EMLD 2024-02-16
O:HBIO240216P00010000 OPASPS Put American 100 10 EMLD 2024-02-16
O:HBIO240216P00009000 OPASPS Put American 100 9 EMLD 2024-02-16
O:HBIO240216P00008000 OPASPS Put American 100 8 EMLD 2024-02-16
O:HBIO240216P00007000 OPASPS Put American 100 7 EMLD 2024-02-16
O:HBIO240216P00006000 OPASPS Put American 100 6 EMLD 2024-02-16
O:HBIO240216P00005000 OPASPS Put American 100 5 EMLD 2024-02-16
O:HBIO240216P00004000 OPASPS Put American 100 4 EMLD 2024-02-16
O:HBIO240216P00003000 OPASPS Put American 100 3 EMLD 2024-02-16
O:HBIO240119P00008000 OPASPS Put American 100 8 EMLD 2024-01-19
O:HBIO240119P00007000 OPASPS Put American 100 7 EMLD 2024-01-19
O:HBIO240119P00006000 OPASPS Put American 100 6 EMLD 2024-01-19
O:HBIO240119P00005000 OPASPS Put American 100 5 EMLD 2024-01-19
O:HBIO240119P00004000 OPASPS Put American 100 4 EMLD 2024-01-19
O:HBIO240119P00003000 OPASPS Put American 100 3 EMLD 2024-01-19
O:HBIO240119P00002000 OPASPS Put American 100 2 EMLD 2024-01-19
O:HBIO240119P00001000 OPASPS Put American 100 1 EMLD 2024-01-19
O:HBIO240119C00008000 OCASPS Call American 100 8 EMLD 2024-01-19
O:HBIO240119C00007000 OCASPS Call American 100 7 EMLD 2024-01-19
O:HBIO240119C00006000 OCASPS Call American 100 6 EMLD 2024-01-19
O:HBIO240119C00005000 OCASPS Call American 100 5 EMLD 2024-01-19
O:HBIO240119C00004000 OCASPS Call American 100 4 EMLD 2024-01-19
O:HBIO240119C00003000 OCASPS Call American 100 3 EMLD 2024-01-19
O:HBIO240119C00002000 OCASPS Call American 100 2 EMLD 2024-01-19
O:HBIO240119C00001000 OCASPS Call American 100 1 EMLD 2024-01-19
O:HBIO231215P00002000 OPASPS Put American 100 2 EMLD 2023-12-15
O:HBIO231215P00001000 OPASPS Put American 100 1 EMLD 2023-12-15
O:HBIO231215C00008000 OCASPS Call American 100 8 EMLD 2023-12-15
O:HBIO231215C00007000 OCASPS Call American 100 7 EMLD 2023-12-15
O:HBIO231215C00006000 OCASPS Call American 100 6 EMLD 2023-12-15
O:HBIO231215C00005000 OCASPS Call American 100 5 EMLD 2023-12-15
O:HBIO231215C00004000 OCASPS Call American 100 4 EMLD 2023-12-15
O:HBIO231215C00003000 OCASPS Call American 100 3 EMLD 2023-12-15
O:HBIO231215C00002000 OCASPS Call American 100 2 EMLD 2023-12-15
O:HBIO231215C00001000 OCASPS Call American 100 1 EMLD 2023-12-15
O:HBIO231215P00008000 OPASPS Put American 100 8 EMLD 2023-12-15
O:HBIO231215P00007000 OPASPS Put American 100 7 EMLD 2023-12-15
O:HBIO231215P00006000 OPASPS Put American 100 6 EMLD 2023-12-15
O:HBIO231215P00005000 OPASPS Put American 100 5 EMLD 2023-12-15
O:HBIO231215P00004000 OPASPS Put American 100 4 EMLD 2023-12-15
O:HBIO231215P00003000 OPASPS Put American 100 3 EMLD 2023-12-15
O:HBIO231117P00010000 OPASPS Put American 100 10 EMLD 2023-11-17
O:HBIO231117P00009000 OPASPS Put American 100 9 EMLD 2023-11-17
O:HBIO231117P00008000 OPASPS Put American 100 8 EMLD 2023-11-17
O:HBIO231117P00007000 OPASPS Put American 100 7 EMLD 2023-11-17
O:HBIO231117P00006000 OPASPS Put American 100 6 EMLD 2023-11-17
O:HBIO231117P00005000 OPASPS Put American 100 5 EMLD 2023-11-17
O:HBIO231117P00004000 OPASPS Put American 100 4 EMLD 2023-11-17
O:HBIO231117P00003000 OPASPS Put American 100 3 EMLD 2023-11-17
O:HBIO231117P00002000 OPASPS Put American 100 2 EMLD 2023-11-17
O:HBIO231117P00001000 OPASPS Put American 100 1 EMLD 2023-11-17
O:HBIO231117C00010000 OCASPS Call American 100 10 EMLD 2023-11-17
O:HBIO231117C00009000 OCASPS Call American 100 9 EMLD 2023-11-17
O:HBIO231117C00008000 OCASPS Call American 100 8 EMLD 2023-11-17
O:HBIO231117C00007000 OCASPS Call American 100 7 EMLD 2023-11-17
O:HBIO231117C00006000 OCASPS Call American 100 6 EMLD 2023-11-17
O:HBIO231117C00005000 OCASPS Call American 100 5 EMLD 2023-11-17
O:HBIO231117C00004000 OCASPS Call American 100 4 EMLD 2023-11-17
O:HBIO231117C00003000 OCASPS Call American 100 3 EMLD 2023-11-17
O:HBIO231117C00002000 OCASPS Call American 100 2 EMLD 2023-11-17
O:HBIO231117C00001000 OCASPS Call American 100 1 EMLD 2023-11-17
O:HBIO231020P00008000 OPASPS Put American 100 8 EMLD 2023-10-20
O:HBIO231020P00007000 OPASPS Put American 100 7 EMLD 2023-10-20
O:HBIO231020P00006000 OPASPS Put American 100 6 EMLD 2023-10-20
O:HBIO231020P00005000 OPASPS Put American 100 5 EMLD 2023-10-20
O:HBIO231020P00004000 OPASPS Put American 100 4 EMLD 2023-10-20
O:HBIO231020P00003000 OPASPS Put American 100 3 EMLD 2023-10-20
O:HBIO231020P00002000 OPASPS Put American 100 2 EMLD 2023-10-20
O:HBIO231020P00001000 OPASPS Put American 100 1 EMLD 2023-10-20
O:HBIO231020C00008000 OCASPS Call American 100 8 EMLD 2023-10-20
O:HBIO231020C00007000 OCASPS Call American 100 7 EMLD 2023-10-20
O:HBIO231020C00006000 OCASPS Call American 100 6 EMLD 2023-10-20
O:HBIO231020C00005000 OCASPS Call American 100 5 EMLD 2023-10-20
O:HBIO231020C00004000 OCASPS Call American 100 4 EMLD 2023-10-20
O:HBIO231020C00003000 OCASPS Call American 100 3 EMLD 2023-10-20
O:HBIO231020C00002000 OCASPS Call American 100 2 EMLD 2023-10-20
O:HBIO231020C00001000 OCASPS Call American 100 1 EMLD 2023-10-20
O:HBIO230915P00010000 OPASPS Put American 100 10 EMLD 2023-09-15
O:HBIO230915P00009000 OPASPS Put American 100 9 EMLD 2023-09-15
O:HBIO230915P00008000 OPASPS Put American 100 8 EMLD 2023-09-15
O:HBIO230915P00007000 OPASPS Put American 100 7 EMLD 2023-09-15
O:HBIO230915P00006000 OPASPS Put American 100 6 EMLD 2023-09-15
O:HBIO230915P00005000 OPASPS Put American 100 5 EMLD 2023-09-15
O:HBIO230915P00004000 OPASPS Put American 100 4 EMLD 2023-09-15
O:HBIO230915P00003000 OPASPS Put American 100 3 EMLD 2023-09-15
O:HBIO230915P00002000 OPASPS Put American 100 2 EMLD 2023-09-15
O:HBIO230915P00001000 OPASPS Put American 100 1 EMLD 2023-09-15
O:HBIO230915C00010000 OCASPS Call American 100 10 EMLD 2023-09-15
O:HBIO230915C00009000 OCASPS Call American 100 9 EMLD 2023-09-15
O:HBIO230915C00008000 OCASPS Call American 100 8 EMLD 2023-09-15
O:HBIO230915C00007000 OCASPS Call American 100 7 EMLD 2023-09-15
O:HBIO230915C00006000 OCASPS Call American 100 6 EMLD 2023-09-15
O:HBIO230915C00005000 OCASPS Call American 100 5 EMLD 2023-09-15
O:HBIO230915C00004000 OCASPS Call American 100 4 EMLD 2023-09-15
O:HBIO230915C00003000 OCASPS Call American 100 3 EMLD 2023-09-15
O:HBIO230915C00002000 OCASPS Call American 100 2 EMLD 2023-09-15
O:HBIO230915C00001000 OCASPS Call American 100 1 EMLD 2023-09-15
O:HBIO230818P00010000 OPASPS Put American 100 10 EMLD 2023-08-18
O:HBIO230818P00009000 OPASPS Put American 100 9 EMLD 2023-08-18
O:HBIO230818P00008000 OPASPS Put American 100 8 EMLD 2023-08-18
O:HBIO230818P00007000 OPASPS Put American 100 7 EMLD 2023-08-18
O:HBIO230818P00006000 OPASPS Put American 100 6 EMLD 2023-08-18
O:HBIO230818P00005000 OPASPS Put American 100 5 EMLD 2023-08-18
O:HBIO230818P00004000 OPASPS Put American 100 4 EMLD 2023-08-18
O:HBIO230818P00003000 OPASPS Put American 100 3 EMLD 2023-08-18
O:HBIO230818P00002000 OPASPS Put American 100 2 EMLD 2023-08-18
O:HBIO230818P00001000 OPASPS Put American 100 1 EMLD 2023-08-18
O:HBIO230818C00010000 OCASPS Call American 100 10 EMLD 2023-08-18
O:HBIO230818C00009000 OCASPS Call American 100 9 EMLD 2023-08-18
O:HBIO230818C00008000 OCASPS Call American 100 8 EMLD 2023-08-18
O:HBIO230818C00007000 OCASPS Call American 100 7 EMLD 2023-08-18
O:HBIO230818C00006000 OCASPS Call American 100 6 EMLD 2023-08-18
O:HBIO230818C00005000 OCASPS Call American 100 5 EMLD 2023-08-18
O:HBIO230818C00004000 OCASPS Call American 100 4 EMLD 2023-08-18
O:HBIO230818C00003000 OCASPS Call American 100 3 EMLD 2023-08-18
O:HBIO230818C00002000 OCASPS Call American 100 2 EMLD 2023-08-18
O:HBIO230818C00001000 OCASPS Call American 100 1 EMLD 2023-08-18
News Stream
Calendar Calendar of Events
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference.
GlobeNewswire Inc. • 2d ago
Stocks Earnings Releases and Operating Results
Harvard Bioscience Announces First Quarter 2024 Financial Results
Strong gross margin performance and focus on efficiency to support ongoing investments in growth Strong gross margin performance and focus on efficiency to support ongoing investments in growth
GlobeNewswire Inc. • 1w ago
Stocks Earnings Releases and Operating Results
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
GlobeNewswire Inc. • 2w ago
Calendar Calendar of Events
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024. Joining him will be Jennifer Cote, the Company’s Chief Financial Officer.
GlobeNewswire Inc. • 2mo ago
News Conference Calls/ Webcasts
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City.
GlobeNewswire Inc. • 6mo ago
Calendar Calendar of Events
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer.
GlobeNewswire Inc. • 6mo ago
Calendar Calendar of Events
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Innovative solutions for academic, CRO, pharma and biotech customers Innovative solutions for academic, CRO, pharma and biotech customers
GlobeNewswire Inc. • 6mo ago
News News
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 2.51%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 9mo ago
Stocks Earnings Releases and Operating Results
Harvard Bioscience Announces Second Quarter 2023 Financial Results
HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2023.
GlobeNewswire Inc. • 9mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT